Literature DB >> 30594404

FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.

Jan P Pennings1, Robbert J de Haas1, Kawthar J A Murshid1, Koert P de Jong2, Rudi A J O Dierckx1, Thomas C Kwee3.   

Abstract

INTRODUCTION: This study aimed to determine the positive predictive value (PPV) of positron emission tomography/computed tomography (PET/CT) with an 18F-fluoro-2-deoxy-D-glucose (FDG)-avid presacral lesion for locally recurrent rectal cancer, and the additional value of magnetic resonance imaging (MRI), including diffusion-weighted imaging (DWI).
MATERIALS AND METHODS: This retrospective study included 38 patients who completed primary rectal cancer treatment and who presented with a suspicious FDG-avid presacral lesion on PET/CT. Twenty-seven patients also underwent MRI, of whom 24 with DWI. PPV of FDG-PET/CT and additional value of MRI, including DWI, for the diagnosis of recurrent presacral cancer were determined.
RESULTS: The PPV of PET/CT with an FDG-avid presacral lesion for the diagnosis of locally recurrent rectal cancer was 58% (22/38). Air in the FDG-avid presacral lesion, as visible on the CT component of the PET/CT examination, favoured the diagnosis of benign presacral tissue with a sensitivity of 56.3% (9/16) and a specificity 81.8% (18/22). Areas under the receiver operating characteristic curve (AUCs) of MRI without DWI for the diagnosis of locally recurrent rectal cancer in FDG-avid presacral tissue were 0.765 and 0.840, for observers 1 and 2. AUCs of MRI with DWI were 0.803 and 0.811, for observers 1 and 2. There were no significant differences among any of these AUCs (P = 0.169 to 0.906).
CONCLUSIONS: FDG-PET/CT has a poor PPV for locally recurrent rectal cancer in the presacral space. The observation of air in the FDG-avid presacral lesion and additional MRI assessment are diagnostically helpful, without a significant additional value of DWI.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  18F-FDG; Diffusion MRI; Magnetic resonance imaging; PET-CT; Rectal cancer

Mesh:

Substances:

Year:  2018        PMID: 30594404     DOI: 10.1016/j.ejso.2018.12.011

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Imaging Diagnosis of Primary Liver Cancer Using Magnetic Resonance Dilated Weighted Imaging and the Treatment Effect of Sorafenib.

Authors:  Bin Fan; Yunyi Zhang; Shuai Guo
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

2.  Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer.

Authors:  Verena Plodeck; Ivan Platzek; Johannes Streitzig; Heiner Nebelung; Sophia Blum; Jens-Peter Kühn; Ralf-Thorsten Hoffmann; Michael Laniado; Enrico Michler; Sebastian Hoberück; Klaus Zöphel; Jörg Kotzerke; Johannes Fritzmann; Jürgen Weitz; Christoph G Radosa
Journal:  Abdom Radiol (NY)       Date:  2021-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.